Endura Therapeutics
PrivateLast Round
Grant
May 15, 2025
Company Overview
Endura Therapeutics is a biotechnology company developing a platform for small molecule drug discovery that targets RNA to create treatments for diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endura Therapeutics Comparables
Compare Endura Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReviR Therapeutics | 86% | |
| Wayfinder Biosciences | 85% | |
| Atomic AI | 84% |
Endura Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2025 | ||||
| Seed | Sep 6, 2024 |
Endura Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scribble Ventures | Seed |
| Calm Ventures | Seed |
| SciFounders | Seed |
| National Science Foundation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
$303K grant received from the National Science Foundation.
- Sep 6, 2024
Raised capital from Calm Ventures, SciFounders, Scribble Ventures, and NSF.
Endura Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Endura Therapeutics's valuation, stock price, and market status.
Is Endura Therapeutics a public or private company?
Endura Therapeutics is a private company.
What is the current stock price of Endura Therapeutics?
Endura Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Endura Therapeutics worth (valuation)?
Valuation information for Endura Therapeutics is not publicly available.
Can I buy Endura Therapeutics stock?
Endura Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Endura Therapeutics's last funding round?
Endura Therapeutics's most recent funding round was Grant on May 15, 2025.
Who are the main investors in Endura Therapeutics?
Key investors in Endura Therapeutics include Scribble Ventures, Calm Ventures, SciFounders, National Science Foundation.
Will Endura Therapeutics IPO soon?
No public IPO plans have been announced for Endura Therapeutics.
How can I track Endura Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Endura Therapeutics's secondary market activity and sign up for updates.